Simufilam did not show a significant reduction in cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's disease in the ReThink-ALZ Phase 3 study Simufilam contin ...
Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava”, the "Company”), a clinical-stage biotechnology company focused on developing ...
(Reuters) -Cassava Sciences on Monday said its experimental Alzheimer's disease drug did not meet the main or secondary goals ...
In this new analysis, the Company reported changes in plasma biomarkers that may reflect Alzheimer's disease pathology. The results demonstrated that individuals who entered the study with plasma ...
Modeled after the state’s $6B cancer research fund, the dementia fund could pump hundreds of millions of dollars into Texas ...
Secret History on MSN1h
Alzheimer Test: Does He Show Symptoms?"This test assesses whether he displays signs of Alzheimer’s disease. David Hoffman presents captivating documentaries and ...
The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years ...
The risk of Alzheimer's disease can be decreased by making healthy food choices, suggested a new study.Research done by a ...
Alzheimer’s disease affects more than 50 million people worldwide, often devastating both the individuals who have it and ...
Cassava Sciences Inc.'s stock (SAVA) was halted after falling 5% in premarket trade Monday, after the company said a trial of a treatment for mild-to-moderate Alzheimer's disease failed to meet its ...
A living will or living trust can also provide additional instructions for how your sister wishes her estate to be handled after her death. Crucially, a trust would help her executor, or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback